Drugs / Glucagon bolus
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03849235 | Mar 2019 → Aug 2025 | cirrhosis of liver, fatty liver disease | Copenhagen University Hospital, Hvidovre | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glucagon bolus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03849235 ↗ |
| Route | Intravenous | “Intravenous bolus of 0.2 mg glucagon” NCT03849235 ↗ |